NCT00002012View on ClinicalTrials.gov

Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Interferon alfa-n3

Trial Locations (1)

10029

Mount Sinai Med Ctr, New York

Sponsors
All Listed Sponsors
lead

Interferon Sciences

INDUSTRY